FDA has approved RINVOQ® (upadacitinib) for the treatment of adults with moderately to severely active Crohn’s disease ...

June 1 marks the start of the 2023 Atlantic hurricane season....

According to the Summer Travel Survey & Trends 2023 report by The Vacationer, a whopping 85% of Americans plan to travel this summer...

“It takes a village,” a common phrase used amongst parents, social media, and the press regarding the magnitude of effort it takes in raising children....

Cision’s 2023 State of the Media Report spotlights challenges and opportunities in rapidly changing media landscape...

Fans showed their support for the Kazakhstan national hockey team in the World Championship of Hockey, with the largest flag of the Republic of Kazakhstan...

The American Foundation for Suicide Prevention (AFSP), the nation’s leading suicide prevention organization, is launching a powerful campaign...

Olympus Corporation, a global medical technology company, teamed up with early onset colon cancer patients and survivors...

Today Vrbo® revealed its 2023 Vacation Homes of the Year....

Student-concepted vessel explores the ocean as new habitable space amidst climate change and rising sea levels ...